No Data
LifeSci Capital Maintains DBV Technologies(DBVT.US) With Buy Rating, Cuts Target Price to $46
Analysts Offer Insights on Healthcare Companies: DBV Technologies SA – American (DBVT) and Kodiak Sciences (KOD)
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
DBV Technologies SA – American (DBVT) Receives a Buy From LifeSci Capital
Wall Street Analysts Are Bullish on Top Healthcare Picks
H.C. Wainwright Maintains DBV Technologies(DBVT.US) With Buy Rating, Maintains Target Price $40